Physician profile
Ned Snyder
NPI 1265413959
$1,714.40
in general payments reported to CMS, 2019-2025
17 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $52.27 · 2021: $253 · 2022: $266 · 2023: $153 · 2024: $424 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $327.33 | 2019 | |
| Tela Bio, INC. | $325.96 | 2024 | Ovitex 2s |
| Abbvie INC. | $163.13 | 2024-2025 | |
| Depuy Synthes Sales INC. | $129.95 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $127.56 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $125.00 | 2023 | |
| Stryker Corporation | $117.28 | 2021 | |
| Janssen Biotech, INC. | $93.24 | 2022-2025 | Simponi Aria, Stelara, Simponi |
| Incyte Corporation | $55.38 | 2022-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $52.46 | 2021-2023 | |
| Integra Lifesciences Corporation | $41.89 | 2024-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Amgen INC. | $34.45 | 2020 | |
| Sientra, INC. | $30.98 | 2022 | |
| Innovation Technologies INC | $27.74 | 2024 | Irrisept |
| Acelrx Pharmaceuticals, INC. | $22.33 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vioptix INC | $21.90 | 2022 | |
| Genzyme Corporation | $17.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ned Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.